Last Updated: April 2026

A life insurance-funded buy-sell agreement is a legally binding contract between business partners that uses life insurance death benefit proceeds to purchase a deceased or disabled partner’s ownership interest at a pre-agreed price, ensuring business continuity without forcing surviving owners to raise acquisition capital at the moment of a partner’s death. The life insurance policy provides a guaranteed, tax-free source of funds at precisely the time they are most needed, allowing the surviving partners to acquire the departing owner’s interest without liquidating business assets, taking on new debt, or negotiating with the deceased partner’s estate under financial pressure. According to the U.S. Small Business Administration (SBA) (2024), fewer than 40% of small businesses with multiple owners have a formally documented and funded buy-sell agreement, leaving the majority of co-owned businesses without a legally enforceable succession mechanism at the time of an owner’s death, disability, or departure.

For business partners, the buy-sell agreement’s purchase price provision is only as reliable as the business valuation supporting it. Sofer Advisors, a nationally recognized business valuation firm headquartered in Atlanta, GA, provides IRS-compliant appraisals that establish the defensible fair market value used in buy-sell agreements, ensuring the agreed purchase price satisfies IRS standards under Revenue Ruling 59-60 and holds up to estate tax scrutiny when an owner dies.

A buy-sell agreement that names a purchase price without a current, defensible business valuation creates three distinct risks: the insurance coverage may be insufficient to fund the actual buyout, the IRS may challenge the purchase price as an understated estate value, and surviving partners may face disputes with the deceased owner’s estate over whether the stated price reflects fair market value. Each of these risks is preventable with a properly structured agreement and a current appraisal.

Key Takeaways

  • Two Primary Structures: Life insurance-funded buy-sell agreements use either a cross-purchase structure (each partner insures the other) or an entity-redemption structure (the business entity owns and is beneficiary of the policies), and the choice has significant tax, basis, and administrative implications.
  • Tax-Free Death Benefit: Life insurance death benefits received by an individual or a business entity are generally income tax-free under IRC §101(a), making insurance proceeds the most tax-efficient source of buyout funding available.
  • Valuation Sets the Coverage Amount: The life insurance policy face amount must equal the departing owner’s fair market value share of the business; an outdated or understated valuation leaves surviving partners underinsured and unable to fund the full buyout.
  • IRS Estate Tax Scrutiny: When a deceased owner’s estate includes a business interest subject to a buy-sell agreement, the IRS will examine whether the agreed purchase price was set at arm’s length and reflects fair market value under IRC §2703; a qualified appraisal is the primary defense.
  • Annual Valuation Review: Because business values change, life insurance coverage amounts and the agreed buy-sell purchase price should be reviewed at least every three to five years, or immediately following a material change in business performance.

The choice of structure and the accuracy of the underlying business valuation together determine whether the buy-sell agreement accomplishes its purpose when a triggering event actually occurs. The sections below examine each element in detail.

What Is a Life Insurance-Funded Buy-Sell Agreement?

A life insurance-funded buy-sell agreement is a succession planning contract that pre-establishes the terms on which one business owner’s interest will be purchased by remaining owners or the business entity itself when a defined triggering event occurs. Triggering events typically include death, permanent disability, retirement, voluntary departure, bankruptcy, and divorce. The life insurance component ensures that buyout funds are available immediately upon the most common and financially disruptive triggering event: the death of a partner.

Without insurance funding, surviving partners must either use business operating cash, take on acquisition debt, negotiate payment terms with the deceased owner’s estate, or admit the estate as a new business partner, all of which create operational disruption, financial strain, or loss of ownership control. Life insurance resolves this liquidity problem by providing a lump sum equal to the insured owner’s share of the business value at the moment the death benefit is payable.

Structure Policy Owner Beneficiary Death Benefit Recipient Number of Policies
Cross-Purchase Each partner individually Other partners Surviving partners (personally) n(n-1) policies
Entity-Redemption Business entity Business entity Business entity One per partner
Wait-and-See Initially entity; converts on death Varies Partners or entity, elected at death One per partner

Why Does the Buy-Sell Purchase Price Matter?

The agreed purchase price in a buy-sell agreement determines the face amount of life insurance required to fully fund the buyout. If a business is worth $4 million and two partners each own 50%, each partner’s interest is worth $2 million. To fund a cross-purchase buyout, each partner would need a $2 million policy on the other. If the business grows to $6 million but the buy-sell agreement and insurance policies are not updated, surviving partners would receive only $2 million in death benefit proceeds but need $3 million to purchase the deceased partner’s now-larger interest, creating a $1 million funding shortfall that must be covered from other sources.

According to the American College of Financial Services (ACFS) (2023), insurance coverage gaps in business buy-sell agreements attributable to outdated valuations represent one of the most common financial planning failures in business succession, with average shortfalls exceeding 30% of the actual buyout obligation in cases where no valuation update occurred within the prior five years. Kroll and Stout’s business valuation advisory practices both report that triggering event claims are most frequently disputed when the agreed buy-sell purchase price was set at formation and never subsequently reviewed against current business value.

What Is the Difference Between the Two Structures?

The two primary life insurance-funded buy-sell structures differ in who owns the policies and who receives the death benefit proceeds, which in turn affects each surviving owner’s income tax basis in the acquired interest.

In a cross-purchase arrangement, each partner individually owns a life insurance policy on each other partner. When a partner dies, the surviving partners receive the death benefit proceeds personally and use those funds to purchase the deceased partner’s interest from the estate. Because the surviving partners are the buyers, they receive a stepped-up income tax basis equal to the full amount paid for the interest, reducing capital gains tax when they eventually sell the business.

In an entity-redemption arrangement, the business entity owns and is the beneficiary of policies on each partner. When a partner dies, the entity receives the proceeds and uses them to redeem the deceased partner’s interest. The surviving partners’ ownership percentages increase without a direct purchase, but their income tax basis in the business does not step up, meaning they carry a larger embedded capital gain when the business is eventually sold.

The key factors in choosing between structures include:

  • Number of partners: Cross-purchase requires n(n-1) policies (e.g., 6 policies for 3 partners), which becomes administratively burdensome with more than 2–3 owners.
  • Partner age and health disparities: Significant age or health differences affect policy premiums; entity-redemption equalizes this because the business entity pays all premiums regardless of which partner is being insured.
  • Income tax basis considerations: Surviving partners in a cross-purchase receive a full cost basis step-up; entity-redemption survivors do not, creating long-term capital gains tax differences on an eventual sale.
  • Corporate alternative minimum tax (AMT) risk: C corporations receiving life insurance death benefits may trigger the corporate AMT under the Inflation Reduction Act (2022), making entity-redemption less advantageous for C corps specifically.

Is your buy-sell agreement adequately funded? Sofer Advisors provides independent business appraisals that establish the fair market value required to set insurance coverage amounts and satisfy IRS documentation requirements. Contact us to request a buy-sell agreement valuation.

How Should Partners Value the Business?

The purchase price provision in a buy-sell agreement can be set using a fixed price, a formula, or a qualified appraisal. Each approach has different reliability characteristics and IRS audit implications.

A fixed price is the simplest approach but requires regular updates; a price set at formation becomes stale within two to three years as the business grows, declines, or changes structurally. A formula (e.g., a multiple of EBITDA or book value) provides automatic updating but may not reflect market conditions, industry-specific valuation methods, or intangible assets that affect actual fair market value. A qualified appraisal by a credentialed appraiser meeting IRS standards under Revenue Ruling 59-60 is the most defensible approach and provides documentation the estate can use to satisfy estate tax reporting requirements under IRC §2703.

According to the American Society of Appraisers (ASA) (2023), buy-sell agreements supported by a current qualified appraisal are significantly less likely to be challenged under IRC §2703 than those using fixed prices or formula-based approaches, because a qualified appraisal directly demonstrates that the purchase price was set at arm’s length and reflects fair market value at the time it was established. Sofer Advisors provides buy-sell agreement appraisals under USPAP (Uniform Standards of Professional Appraisal Practice) and Revenue Ruling 59-60 standards across all industries, with each appraisal report structured to support both insurance coverage determinations and estate tax filing requirements.

How Often Should Buy-Sell Coverage Be Updated?

Buy-sell agreement valuations and corresponding life insurance coverage amounts should be reviewed at least every three to five years under normal circumstances and immediately following any material change in business performance or structure. Specific events that require an immediate review include:

  • Significant revenue change: A year-over-year revenue increase or decrease exceeding 20% materially affects fair market value and may create a coverage gap or overfunded position.
  • Owner addition or departure: Adding a new partner or losing a key owner changes both the ownership structure and the insurance requirements for all remaining parties.
  • Major capital investment or acquisition: Completing a significant expansion, acquiring a competitor, or divesting a business unit changes the asset base and valuation inputs used at funding.
  • Change in industry multiples: Shifts in comparable transaction or EBITDA multiples within the business’s sector can substantially alter fair market value independent of the business’s own financial performance.
  • Owner health change: A significant change in an insured partner’s health may affect insurability and premium structure, requiring review of whether coverage can be maintained at the required amount.

The review process requires obtaining a new qualified business appraisal, adjusting the buy-sell agreement’s purchase price provision (or confirming that a formula approach remains appropriate), and increasing life insurance coverage amounts to match the updated valuation. Failure to update creates both a coverage gap that surviving partners must fund from other sources and an increased IRS audit risk under IRC §2703 if the buy-sell price at death departs significantly from the business’s actual fair market value at that time.

Frequently Asked Questions

What is the most common way to fund a buy-sell agreement?

Life insurance is the most common funding method for buy-sell agreements because the death benefit is income tax-free under IRC §101(a), the proceeds are available immediately upon the insured partner’s death, and no cash reserves or credit capacity need to be maintained for the purpose. Installment payment arrangements and sinking funds are alternatives but leave surviving partners exposed to liquidity constraints at the time of a triggering event.

What happens if the buy-sell agreement purchase price is too low at death?

If the IRS determines that the agreed purchase price was below fair market value at the time of a partner’s death, it may disregard the buy-sell price under IRC §2703 and include the full fair market value of the business interest in the deceased owner’s taxable estate, resulting in additional estate tax liability. To prevent this, the buy-sell price must be set at arm’s length and reflect fair market value at the time it is established, supported by a qualified appraisal.

How many life insurance policies are needed in a cross-purchase buy-sell?

In a cross-purchase structure, each partner must own a policy on every other partner, resulting in n(n-1) policies total. For two partners, two policies are needed. For three partners, six policies are required. For businesses with more than three partners, entity-redemption is often preferred because it requires only one policy per partner, owned by the business entity.

Can a buy-sell agreement cover disability as well as death?

Yes. Most well-structured buy-sell agreements include disability as a triggering event alongside death. Disability buyouts are typically funded using disability buyout insurance, which pays a lump sum or installment payments upon the insured partner’s permanent total disability. Disability coverage is typically more expensive than life insurance and requires a waiting period before benefits are payable, so the buy-sell agreement’s disability provisions must align precisely with the policy terms.

Does the business entity have to pay income tax on life insurance proceeds under entity-redemption?

Generally, no. Life insurance death benefit proceeds received by a business entity are income tax-free under IRC §101(a) for C corporations, S corporations, and partnerships. However, C corporations should evaluate whether the proceeds trigger the corporate alternative minimum tax (AMT) under the Inflation Reduction Act (2022), which imposes a 15% minimum tax on adjusted financial statement income for certain corporations, potentially including large life insurance proceeds.

What is a wait-and-see buy-sell agreement?

A wait-and-see buy-sell agreement gives the business entity and surviving partners flexibility at the time of a triggering event to elect either an entity-redemption or cross-purchase structure based on which is more tax-advantageous at that moment. The entity typically holds the life insurance policy, but the proceeds can be used by the entity to redeem the interest or distributed to surviving partners to fund a cross-purchase. This structure adds flexibility but requires careful drafting to ensure the election mechanism functions as intended.

How is the buy-sell agreement purchase price treated for estate tax purposes?

Under IRC §2703, a buy-sell agreement will be respected for estate tax purposes only if it is a bona fide business arrangement, not a testamentary device, and the price is comparable to what unrelated parties would agree to in an arm’s-length transaction. A buy-sell agreement supported by a qualified appraisal at the time the price is established, with a documented review history, has the strongest available defense against IRC §2703 challenge.

Should buy-sell agreement life insurance be owned by a trust?

In some estate planning strategies, life insurance policies in a cross-purchase buy-sell are owned by an irrevocable life insurance trust (ILIT) rather than individually by each partner, to keep the death benefit proceeds out of the insured partner’s gross estate. This is more commonly applicable where the partners have large estates that may be subject to estate tax, and should be evaluated with an estate planning attorney based on each partner’s specific estate tax exposure.

How much does a buy-sell agreement valuation from Sofer Advisors cost?

A buy-sell agreement valuation from Sofer Advisors typically ranges from $7,500 to $25,000 depending on the business’s revenue, industry, and the number of valuation approaches required to support insurance coverage determinations and IRS documentation under IRC §2703. Engagements are generally completed in four to eight weeks from document receipt. For a fee estimate based on your agreement’s specifics, contact Sofer Advisors.

Related Case Studies

Executive Summary

A life insurance-funded buy-sell agreement is the standard mechanism for ensuring business continuity and providing a guaranteed source of buyout proceeds when a business partner dies or becomes permanently disabled. The two primary structures, cross-purchase and entity-redemption, differ in ownership, tax basis treatment, and administrative complexity, and the choice between them depends on the number of partners, their relative ages and health, and long-term capital gains tax strategy. In both structures, the life insurance face amount must match the insured partner’s share of the business’s fair market value, requiring a current, qualified appraisal at agreement formation and periodic updates thereafter. The IRS can challenge a buy-sell purchase price under IRC §2703 if it does not reflect arm’s-length fair market value at the time it is established, making a documented, professionally prepared appraisal the primary defense against estate tax disputes. Sofer Advisors provides IRS-compliant buy-sell agreement valuations that establish the defensible purchase price needed to fund coverage correctly and satisfy estate tax reporting requirements.

What Should You Do Next?

Sofer Advisors provides independent business appraisals specifically structured for buy-sell agreement funding, IRC §2703 compliance, and estate tax reporting. David Hern CPA ABV ASA, founder of Sofer Advisors, and his team of 14 credentialed valuation professionals have delivered qualified buy-sell agreement appraisals for businesses across healthcare, professional services, manufacturing, and technology sectors. Schedule a free consultation to discuss how a current business valuation protects your buy-sell agreement’s purchase price.

People Also Read

About the Author

This guide was prepared by David Hern CPA ABV ASA, founder of Sofer Advisors – a business valuation firm headquartered in Atlanta, GA serving clients across the United States. David holds dual accreditations as an Accredited Senior Appraiser (ASA) and is Accredited in Business Valuation (ABV), credentials recognized by the IRS, SEC, and FINRA. He also holds the Certified Exit Planning Advisor (CEPA) designation. With 15+ years of valuation experience, David has served as an expert witness in 11+ cases across multiple jurisdictions and built Sofer Advisors into an Inc. 5000-recognized firm with 180+ five-star Google reviews. The firm’s full W2 employee team maintains subscriptions to all major valuation databases and operates under a next business day response policy.

For professional business valuation services, visit soferadvisors.com or schedule a consultation.

This content is for informational purposes only and does not constitute professional valuation advice. Business valuation conclusions depend on specific facts and circumstances. Contact Sofer Advisors for guidance regarding your specific situation.